A kind of hydroxamic acid compound and its preparation method and application

A compound and hydroxime technology, applied in the field of hydroxamic acid compounds, can solve problems such as abnormal gene inhibition

Active Publication Date: 2016-01-06
CHENGDU DIAO JIU HONG PHARMACEUTICAL FACTORY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In general, the enhancement of histone acetylation level is related to the enhancement of gene transcription activity, while the low level of acetylation is related to the inhibition of gene expression (ForsbergEC, BresnickEH. :820-830). Studies have found that HDAC is overexpressed and recruited by transcription factors, leading to abnormal suppression of specific genes, leading to tumors and other diseases; and inhibiting the activity of HDAC will cause growth inhibition and apoptosis of many cancer cells ( SomechR, IzraeliS, JSimonA. Histone deacetylase inhibitors-a new tool to treat cancer [J]. Cancer Treat Rev, 2004, 30 (5): 461-472)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of hydroxamic acid compound and its preparation method and application
  • A kind of hydroxamic acid compound and its preparation method and application
  • A kind of hydroxamic acid compound and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0075] The preparation of embodiment 12-[4-benzamide cyclohexylidene] methyl acetate:

[0076] Step 1, utilize the witting reaction principle to prepare 2-[4-(N-tert-butoxycarbonylamino) cyclohexylidene] methyl acetate:

[0077] In the there-necked flask with drying tube, reflux condenser and thermometer, add 2.13g (10mmol) 4-N-tert-butoxycarbonylaminocyclohexanone, 2.73g (15mmol) trimethyl phosphonoacetate and 100ml tetrahydrofuran, After stirring and dissolving, add 0.42g (17.5mmol) lithium hydroxide and 15g4A molecular sieve, stir at room temperature for a few minutes, then raise the temperature and reflux for 10 hours. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure to obtain a white solid product with a yield of 95%.

[0078] Step 2, prepare 2-(4-aminocyclohexylene) methyl acetate:

[0079] In a single-necked bottle with a drying tube, add 2.69g (10mmol) methyl 2-[4-(N-tert-butoxycarbonylamino)cyclohexylene]acetate, 50ml dichl...

Embodiment 2

[0082] The preparation of embodiment 22-[4-(2-quinoline carboxamide) cyclohexylidene] methyl acetate

[0083] Step 1 and Step 2 refer to Example 1.

[0084] Step 3: Add 5.19g (30mmol) of quinoline 2-carboxylic acid and 200ml of tetrahydrofuran into a single-necked bottle with a drying tube, stir and dissolve, then add 8.92g of HBTU (23.54mmol) and 60ml of N,N-dimethylformamide, Stir at room temperature for half an hour, then add 3.62 g (21.4 mmol) of methyl 2-(4-aminocyclohexylene) acetate, adjust the pH to ≥ 8 with diisopropylethylamine, and continue stirring at room temperature for 8 hours. The reaction mixture was concentrated in vacuo, 100 ml of water was added to the residue, and a milky white solid was precipitated by shaking and shaking. The milky white solid was dissolved in ethyl acetate, washed twice with water, 5% potassium carbonate, 2% hydrochloric acid, and saturated brine, and dried over anhydrous sodium sulfate. After suction filtration, the solvent was evapo...

Embodiment 3

[0085] Preparation of Example 32-[4-(8-quinolinesulfonamide)cyclohexylene]methyl acetate

[0086] Step 1 and Step 2 refer to Example 1.

[0087] Step 3, in the three-necked flask, add 3.38g (20mmol) 2-(4-aminocyclohexylene) methyl acetate and 6.06g (60mmol) triethylamine, stir and dissolve with 80ml dichloromethane, and cool in an ice bath to At 0° C., a dichloromethane solution of 6.83 g (30 mmol) quinoline 8-sulfonyl chloride was added dropwise. During the dropwise addition, the temperature was kept at 0-5°C, and then gradually raised to room temperature and stirred for three hours. The reaction mixture was concentrated in vacuo, washed successively with saturated sodium bicarbonate solution and saturated brine twice, and dried over anhydrous sodium sulfate. After suction filtration, the solvent was evaporated under reduced pressure, and the pure product was obtained by column chromatography with a yield of 65%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a hydroxamic acid compound and a preparation method as well as application of the compound. The invention also discloses a medicine combination for restraining the activity of histone deacetylase. The hydroxamic acid compound provided by the invention has good inhibitory effect on the HDAC in vitro, can also enter tumor cells to inhibit the activity of the HDAC in the tumor cells and enhance the expression of acetylated histone and cycle-related proteins and has the anti-tumor effect; and the anti-tumor effect of the hydroxamic acid compound is obviously superior to that of SAHA.

Description

technical field [0001] The invention relates to a hydroxamic acid compound, its preparation method and application. Background technique [0002] Inactivation of genes that control cell growth in the body is a hallmark of tumorigenesis. The epigenetic mechanisms that cause gene inactivation mainly include DNA methylation, histone acetylation, and modifications of other components in the higher-order structure of chromatin. These modifications change the chromatin configuration, resulting in changes in the regulation of gene transcription. Improper cell proliferation, leading to tumors. [0003] 40 years ago, Allfrey et al. realized that the acetylation process of histones is closely related to the regulation of eukaryotic gene transcription (AllfreyVG, FaulknerR, MirskyAE. Acetylation and methylation of histones and their possible role inheregulation of RNA synthesis [J]. ProcNatlAcadSciUSA, 1964, 51: 786-794). Histone acetylation plays a central role in the regulation of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07C259/06C07D215/48C07D209/42C07D307/85C07D215/36C07D217/02C07D317/68A61K31/166A61K31/343A61K31/404A61K31/47A61K31/472A61K31/36A61P35/00A61P35/02
CPCY02P20/55
Inventor 王学超张萧洁吴逢伟余飞江邓林根杜勇华朱学军
Owner CHENGDU DIAO JIU HONG PHARMACEUTICAL FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products